MI078胶囊用于治疗产后抑郁症患者的有效性和安全性的多中心、随机、双盲、安慰剂平行对照的Ⅱ期临床试验
[Translation] A multicenter, randomized, double-blind, placebo-controlled phase II clinical trial of the efficacy and safety of MI078 capsules in the treatment of postpartum depression
评价MI078胶囊用于治疗产后抑郁症患者的有效性,探索MI078胶囊用于治疗产后抑郁症的最佳剂量。评估MI078胶囊用于治疗产后抑郁症患者的安全性。
[Translation] To evaluate the effectiveness of MI078 capsules in the treatment of postpartum depression, explore the optimal dose of MI078 capsules in the treatment of postpartum depression, and evaluate the safety of MI078 capsules in the treatment of postpartum depression.
/ Active, not recruitingPhase 1 MI078胶囊在中国健康受试者中单次和多次给药的耐受性、安全性、药代动力学和食物影响的I期临床研究
[Translation] Phase I clinical study of the tolerability, safety, pharmacokinetics and food effects of single and multiple doses of MI078 capsules in healthy Chinese subjects
研究MI078胶囊在中国健康受试者中单次和多次给药的耐受性、安全性、药代动力学和食物影响
[Translation] To investigate the tolerability, safety, pharmacokinetics and food effects of single and multiple doses of MI078 capsules in healthy Chinese subjects
100 Clinical Results associated with Minover (Wuxi) Pharmaceutical Technology Co., Ltd.
0 Patents (Medical) associated with Minover (Wuxi) Pharmaceutical Technology Co., Ltd.
100 Deals associated with Minover (Wuxi) Pharmaceutical Technology Co., Ltd.
100 Translational Medicine associated with Minover (Wuxi) Pharmaceutical Technology Co., Ltd.